國立高雄大學圖資館 |

Language: English

Back

Diagnosis, management and emerging s...

Loprinzi, Charles.

Diagnosis, management and emerging strategies for chemotherapy-induced neuropathya MASCC book /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Diagnosis, management and emerging strategies for chemotherapy-induced neuropathyedited by Maryam Lustberg, Charles Loprinzi.
Reminder of title:	a MASCC book /
other author:	Lustberg, Maryam.
Published:	Cham :Springer International Publishing :2021.
Description:	viii, 263 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Nerves, PeripheralDiseases.
Online resource:	https://doi.org/10.1007/978-3-030-78663-2
ISBN:	9783030786632$q(electronic bk.)

Diagnosis, management and emerging strategies for chemotherapy-induced neuropathya MASCC book /
Diagnosis, management and emerging strategies for chemotherapy-induced neuropathya MASCC book /[electronic resource] :edited by Maryam Lustberg, Charles Loprinzi. - Cham :Springer International Publishing :2021. - viii, 263 p. :ill., digital ;24 cm.

Natural History of Chemotherapy Induced Neuropathy -- Predisposing factors for the development of CIPN -- Evaluation of Chemotherapy-Induced Peripheral Neuropathy -- Preventive Strategies for Chemotherapy-in-duced Peripheral Neuropathy -- Prevention of CIPN - Current Clinical Data and Future Directions -- Treatment of established CIPN: basic science and animal models -- Pharmacological Treatment of Established CIPN -- Systematic review of exercise for prevention and management of chemotherapy-induced peripheral neuropathy -- Clinical and practical recommendations in the use of exercise, physical therapy, and occupational therapy for chemotherapy-induced peripheral neuropathy -- Natural course of neurotoxicity after immune checkpoint inhibitor (ICI) exposure -- Ants and Needles and Pins - Living with Neuropathy.

This book comprehensively examines chemotherapy-induced peripheral neuropathy (CIPN), a common dose-limiting condition that negatively affects both the quality of life of cancer patients and disease outcomes. CIPN remains a challenging area for both clinical care and research, as there are multiple unresolved issues. Written by leading international experts, the book discusses the natural history of CIPN, the latest predictors of toxicity, instruments for evaluating symptoms, and prevention/therapeutic strategies, as well as patients' experiences of this common clinical syndrome. Lastly it highlights avenues for future research to enhance our understanding of CIPN. Providing essential information on the management of CIPN and the latest research in the field, this book is a valuable resource for researchers and healthcare providers working with patients with various malignant diseases.

ISBN: 9783030786632$q(electronic bk.)

Standard No.: 10.1007/978-3-030-78663-2doiSubjects--Topical Terms:

504225
Nerves, Peripheral
--Diseases.

LC Class. No.: RC409 / .D53 2021

Dewey Class. No.: 616.856

Diagnosis, management and emerging strategies for chemotherapy-induced neuropathya MASCC book /
LDR:02774nmm a2200325 a 4500 001 610334
003 DE-He213
005 20211007125922.0
006 m d
007 cr nn 008maaau
008 220330s2021 sz s 0 eng d
020 $a 9783030786632$q(electronic bk.)
020 $a 9783030786625$q(paper)
024 7 $a 10.1007/978-3-030-78663-2 $2 doi
035 $a 978-3-030-78663-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC409 $b .D53 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.856 $2 23
090 $a RC409 $b .D536 2021
245 0 0 $a Diagnosis, management and emerging strategies for chemotherapy-induced neuropathy $h [electronic resource] : $b a MASCC book / $c edited by Maryam Lustberg, Charles Loprinzi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a viii, 263 p. : $b ill., digital ; $c 24 cm.
505 0 $a Natural History of Chemotherapy Induced Neuropathy -- Predisposing factors for the development of CIPN -- Evaluation of Chemotherapy-Induced Peripheral Neuropathy -- Preventive Strategies for Chemotherapy-in-duced Peripheral Neuropathy -- Prevention of CIPN - Current Clinical Data and Future Directions -- Treatment of established CIPN: basic science and animal models -- Pharmacological Treatment of Established CIPN -- Systematic review of exercise for prevention and management of chemotherapy-induced peripheral neuropathy -- Clinical and practical recommendations in the use of exercise, physical therapy, and occupational therapy for chemotherapy-induced peripheral neuropathy -- Natural course of neurotoxicity after immune checkpoint inhibitor (ICI) exposure -- Ants and Needles and Pins - Living with Neuropathy.
520 $a This book comprehensively examines chemotherapy-induced peripheral neuropathy (CIPN), a common dose-limiting condition that negatively affects both the quality of life of cancer patients and disease outcomes. CIPN remains a challenging area for both clinical care and research, as there are multiple unresolved issues. Written by leading international experts, the book discusses the natural history of CIPN, the latest predictors of toxicity, instruments for evaluating symptoms, and prevention/therapeutic strategies, as well as patients' experiences of this common clinical syndrome. Lastly it highlights avenues for future research to enhance our understanding of CIPN. Providing essential information on the management of CIPN and the latest research in the field, this book is a valuable resource for researchers and healthcare providers working with patients with various malignant diseases.
650 0 $a Nerves, Peripheral $x Diseases. $3 504225
650 0 $a Nerves, Peripheral $x Diseases $x Treatment. $3 908375
650 0 $a Drugs $x Side effects. $3 375432
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Neurosciences. $3 211508
650 2 4 $a Physiology. $3 192980
700 1 $a Lustberg, Maryam. $3 908373
700 1 $a Loprinzi, Charles. $3 908374
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-78663-2
950 $a Biomedical and Life Sciences (SpringerNature-11642)